Objectives
  • To be able to perform specialist assessment, treatment and counselling of patients with basal cell cancer (BCC) and squamous cell cancer (SCC) of the skin, including secondary prevention

Awareness
  • Awareness of the existence of different biological and pathological subtypes of skin cancer, ie, non-melanoma skin cancers versus melanoma, hereditary versus spontaneous forms, for the selection of the appropriate treatment strategies

  • Awareness of the existence of SCC at non-skin sites, eg, lung, prostate, thyroid etc

  • Awareness of the existence of different prognostic factors

  • Awareness of the diagnostic work-up using microscopy and biopsy as well as that the pathological appearance of SCC varies with the depth of the biopsy

  • Appreciation of the importance of the differences in treatment approaches in localised versus metastatic disease and in hereditary versus spontaneous disease

Knowledge
  • Understanding of the causes of BCC, actinic keratosis (AK) and SCC, ie, primarily sun exposure, but also long-term complications of cancer therapy or human papilloma virus (HPV) infection (SCC only)

  • Understanding of the long latency period of up to 30 years between sun exposure and occurrence of skin cancer lesions

  • Familiarity with the implications of the different biological and pathological subtypes of skin cancer for the selection of appropriate treatment strategies

  • Familiarity with the risk assessment work-up of prognostic factors, especially the TNM staging system for BCC and SCC and their implications for treatment choice

  • Familiarity with the indications and value of surgery, cryotherapy, chemotherapy, photodynamic therapy, radiotherapy, laser therapy, creams and lotions, targeted agents, but also with their limitations (eg, criteria of inoperability, aspects pertaining to metastatic disease, side effect profiles)

  • Understanding of the role of targeted agents in the management of patients with advanced disease, including genetic variants determining mechanisms of resistance towards targeted therapies

  • Understanding of disease dynamics and associated treatment strategies in hereditary disease (Gorlin–Goltz syndrome)

  • Familiarity with the conditions in which the various surgical and non-surgical treatments are performed

Skills
  • Ability to contribute actively to a variety of BCC, SCC and AK clinical scenarios and patient presentations

  • Ability to discuss critically the treatment options/recommendations

  • Ability to perform a history and physical examination in patients with non-melanoma skin cancer

  • Ability to contribute to discussions on general management strategies in order to understand all the considerations on which treatment to use

  • Ability to manage side effects of various chemotherapeutic and targeted agents

  • Ability to discuss with patients the special considerations in the management of hereditary disease (Gorlin–Goltz syndrome), especially with regard to speed of recurrence, the large number of lesions and cosmetic sequelae

  • Ability to discuss prevention strategies with patients, especially sun protection